2025 United States Bioprocess Technology Market Revenue Opportunities Report
Description
The 2025 United States Bioprocess Technology Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Bioprocess Technology Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the bioprocess technology market in the United States include Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, and Lonza Group AG. Thermo Fisher Scientific is a global leader offering comprehensive bioprocessing solutions, including single-use technologies and platforms for gene therapy production, serving major biopharma manufacturers. Danaher Corporation is notable for its diversified life sciences tools that support bioprocessing efficiency. Sartorius AG provides bioprocess equipment and consumables, with significant growth driven by biologics demand. Lonza, a major contract development and manufacturing organization, facilitates scalable biomanufacturing for pharma and biotech sectors.
Other important players in the US include advanced biopharma firms like Amgen and Gilead Sciences, which integrate bioprocess technology into biologic drug production. The US bioprocess market benefits from strong R&D investments, adoption of single-use systems, regulatory support for cell and gene therapies, and robust healthcare infrastructure, positioning North America as the leading regional market with over 44.5% market share in 2024. These companies are crucial drivers of innovation and production scale in monoclonal antibodies, vaccines, biosimilars, and gene therapies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Bioprocess Technology Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the bioprocess technology market in the United States include Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, and Lonza Group AG. Thermo Fisher Scientific is a global leader offering comprehensive bioprocessing solutions, including single-use technologies and platforms for gene therapy production, serving major biopharma manufacturers. Danaher Corporation is notable for its diversified life sciences tools that support bioprocessing efficiency. Sartorius AG provides bioprocess equipment and consumables, with significant growth driven by biologics demand. Lonza, a major contract development and manufacturing organization, facilitates scalable biomanufacturing for pharma and biotech sectors.
Other important players in the US include advanced biopharma firms like Amgen and Gilead Sciences, which integrate bioprocess technology into biologic drug production. The US bioprocess market benefits from strong R&D investments, adoption of single-use systems, regulatory support for cell and gene therapies, and robust healthcare infrastructure, positioning North America as the leading regional market with over 44.5% market share in 2024. These companies are crucial drivers of innovation and production scale in monoclonal antibodies, vaccines, biosimilars, and gene therapies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
